Is Mounjaro More Effective Than Rybelsus and Victoza? Explained by an Osaka Dermatologist

Hello, I’m Dr. Koji Kato, Director of A&O Clinic Osaka Nakatsu.

Today, I’ll explain whether Mounjaro (Tirzepatide) is more effective than Rybelsus (Semaglutide) or Victoza (Liraglutide) in terms of weight loss and blood sugar control.

Mounjaro, like Rybelsus and Victoza, is used as a GLP-1 receptor agonist, but it has a special feature that sets it apart. Mounjaro is a dual incretin agonist, meaning it acts not only on GLP-1 receptors but also on GIP receptors. This dual action enhances its ability to promote more effective weight loss and blood sugar control compared to other GLP-1 agonists.

Summary

Mounjaro (Tirzepatide) is significantly more effective than Rybelsus (Semaglutide) and Victoza (Liraglutide) in terms of both weight reduction and blood sugar control. The dual action of Mounjaro on GLP-1 and GIP receptors offers benefits that cannot be achieved by other medications.

Weight loss effects: Mounjaro > Rybelsus > Victoza

Blood sugar control effects: Mounjaro > Rybelsus > Victoza

While Mounjaro provides stronger effects, it also shares similar side effects with other drugs, so selecting the right medication for each patient depends on their individual conditions.

A&O Clinic Osaka Nakatsu

3-13-6 Toyosaki, Kita-ku, Osaka-shi, Osaka

Fuji Terrace Osaka Umeda 5F (Next to Kawaijuku Osaka Campus)

TEL: 06-6375-5888

LINE ID: @671vfvts

2-minute walk from Midosuji Line Nakatsu Station, Exit 4

7-minute walk from Hankyu Umeda Station